Welcome to our dedicated page for Edgewell Pers Care Co SEC filings (Ticker: EPC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Edgewell Personal Care Company (NYSE: EPC) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents offer detailed insight into how Edgewell manages its personal care portfolio, finances and governance, and they are a key resource for anyone analyzing EPC stock.
Investors can review annual reports on Form 10-K for comprehensive discussions of Edgewell’s business, risk factors and performance across its Wet Shave, Sun and Skin Care and Feminine Care segments. Quarterly reports on Form 10-Q update these disclosures with more frequent financial and operational information, including segment results and commentary on market conditions, tariffs and foreign exchange impacts.
Edgewell also files current reports on Form 8-K to describe material events. Recent 8-K filings have covered quarterly and annual earnings releases and the asset purchase agreement to sell the Feminine Care business to Essity, including key terms and closing conditions. These filings help investors track significant strategic decisions, restructuring actions and leadership changes.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) outlines board composition, governance practices, executive compensation programs, shareholder proposals and the agenda for the annual meeting. It also includes management’s discussion of strategy, portfolio transformation and recognition for sustainability and workplace achievements.
On Stock Titan, Edgewell’s filings are supplemented with AI-powered summaries that explain the main points of lengthy documents such as 10-Ks, 10-Qs, 8-Ks and proxy statements in clear language. Real-time updates from EDGAR ensure new filings appear promptly, while specialized views make it easier to locate items such as insider transaction reports on Form 4, stock incentive plan details and other disclosures relevant to EPC shareholders.
Edgewell Personal Care (EPC) CFO reported routine equity transactions on Form 4 tied to restricted stock equivalents vesting. On 11/10/2025, 1,023 shares of common stock were acquired at $0 upon vesting, followed by 356 shares withheld at $18.83 to cover taxes. On 11/11/2025, an additional 780 shares vested at $0, with 272 shares withheld at $18.57 for taxes.
Following these transactions, the CFO directly holds 25,740 shares of EPC common stock. The filing labels the acquisitions as code “M” (conversion of derivative securities) and the withholdings as code “F” (tax withholding), consistent with standard equity award vesting mechanics.
Edgewell Personal Care (EPC): Form 4 insider activity
Officer Jessica Spence, President, North America, reported the vesting and conversion of 4,425 restricted stock equivalents into EPC common stock on 11/08/2025 (Code M) at an exercise price of $0. To satisfy tax obligations, 2,390 shares were withheld (Code F) at a price of $18.83.
Following these transactions, the reporting person directly owns 2,035 shares of EPC common stock. The filing also lists 8,850 derivative securities (restricted stock equivalents) beneficially owned after the reported activity.
Edgewell Personal Care insider filing shows executive departure and resulting equity changes. The Form 4 reports that Daniel Sullivan, the company's Chief Operating Officer, departed on October 1, 2025, triggering the disposition and forfeiture of equity awards. The filing records a disposition of 90,418 shares of common stock and notes that several unvested awards were forfeited upon departure. The form also lists multiple vested stock options and restricted stock equivalents that remained exercisable or convertible after departure, with holders typically having 90 days to exercise vested options. The filing is signed by an attorney-in-fact on October 2, 2025 and includes detailed counts and exercise prices for each option and award.
Brandes Investment Partners, L.P. reports a passive beneficial ownership stake of 5,063,875 common shares of Edgewell Personal Care Co, representing 10.90% of the outstanding class. The filing states Brandes has shared voting power over 3,194,614 shares and shared dispositive power over the full 5,063,875 shares, with no sole voting or dispositive power.
This Schedule 13G/A indicates the position is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The filing lists Brandes as an investment adviser/parent nominee type and provides issuer and reporting-person addresses and CUSIP for identification.
Edgewell Personal Care Company announced that Daniel J. Sullivan, its Chief Operating Officer, informed the company on
Brandes Investment Partners, L.P. reports beneficial ownership of 4,598,440 common shares of Edgewell Personal Care Co. The filing shows shared voting power of 2,889,673 shares and shared dispositive power over 4,598,440 shares, with no sole voting or dispositive power reported.
The document is a Schedule 13G/A indicating passive intent and identifies the reporting person types as IA, PN. The filing lists the stake as 9.8% in one section and as 6.81% in Item 4(b), an inconsistency present in the reported percentages. The signatory certifies the holdings were acquired in the ordinary course of business and not to influence control.
Edgewell Personal Care Company (EPC) filed a Form 8-K to disclose that, on 5 Aug 2025, it issued a press release announcing fiscal Q3 2025 operating and financial results. The release is furnished as Exhibit 99.1; no quantitative figures are included in the filing itself. The information is furnished under Item 2.02 and, per SEC rules, is not deemed "filed" for liability purposes nor incorporated into other securities filings unless specifically referenced.